Log in to search using one of your social media accounts:

 

Medical News Today: One injection could kill cancer
Groundbreaking cancer research might have uncovered a 'one-time application' formula that can help immune cells to eliminate cancer tumors. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - February 1, 2018 Category: Consumer Health News Tags: Cancer / Oncology Source Type: news

Africa:Cancer Is Costing Brics Economies Billions Each Year
[The Conversation Africa] Premature - and potentially avoidable - death from cancer is costing tens of billions of dollars in lost productivity in a group of key developing economies. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - February 1, 2018 Category: African Health Source Type: news

Cancer 'Vaccine' Rids Body of Multiple Cancer Types -- in Mice
Title: Cancer 'Vaccine' Rids Body of Multiple Cancer Types -- in MiceCategory: Health NewsCreated: 1/31/2018 12:00:00 AMLast Editorial Review: 2/1/2018 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - February 1, 2018 Category: Cancer & Oncology Source Type: news

Low-risk thyroid nodules safe to track with ultrasound
It's safe to use ultrasound to track thyroid nodules that don't have suspicious...Read more on AuntMinnie.comRelated Reading: Thyroid nodule imaging surveillance offers low yield USPSTF recommends against thyroid cancer screening Second Opinion: Did thyroid imaging study miss the mark? Machine learning may aid reading of thyroid ultrasound Does imaging after thyroid cancer treatment help? (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 1, 2018 Category: Radiology Source Type: news

Potential California Warning: The Chemical In Your Coffee That May Cause Cancer
Soon coffee sellers and servers in California may need to display a Proposition 65 sign declaring coffee a potential health risk (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - February 1, 2018 Category: Pharmaceuticals Authors: Bruce Y. Lee, Contributor Source Type: news

Roche reports good results in 2017
Commenting on the Group ’s results, Roche CEO Severin Schwan said: “In 2017, we made significant progress with good growth in both divisions driven by newly launched medicines and tests. I am particularly pleased with the successful launch of Ocrevus and Hemlibra and important approvals for additional indications for P erjeta, Tecentriq and Alecensa. These medicines bring substantial benefit to patients with serious diseases such as multiple sclerosis, cancer and haemophilia. Based on our strong product portfolio we are well positioned for the future.” (Source: Roche Investor Update)
Source: Roche Investor Update - February 1, 2018 Category: Pharmaceuticals Source Type: news

Roche reports good results in 2017
Commenting on the Group ’s results, Roche CEO Severin Schwan said: “In 2017, we made significant progress with good growth in both divisions driven by newly launched medicines and tests. I am particularly pleased with the successful launch of Ocrevus and Hemlibra and important approvals for additional indications for P erjeta, Tecentriq and Alecensa. These medicines bring substantial benefit to patients with serious diseases such as multiple sclerosis, cancer and haemophilia. Based on our strong product portfolio we are well positioned for the future.” (Source: Roche Media News)
Source: Roche Media News - February 1, 2018 Category: Pharmaceuticals Source Type: news

Toy Foundation grants Nemours $825,000 to date for pediatric trauma-informed care
(Nemours) Children who face hospitalization for conditions such as cancer often experience traumatic stress related to their illness and treatment. The Toy Foundation is funding Nemours' research into the use of play as an intervention to lessen the traumatic nature of medical events or prevent traumatic stress in children. The idea is to emphasize physical and emotional safety through play to help patients and their families rebuild a sense of control and empowerment. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 1, 2018 Category: Cancer & Oncology Source Type: news

New international practice guidelines for tamoxifen treatment based on CYP2D6 genotype
(Mayo Clinic) An international group of clinicians and scientists representing the Clinical Pharmacogenetics Implementation Consortium (CPIC) published the first-ever clinical practice guideline for using CYP2D6 genotype to guide tamoxifen therapy in Clinical Pharmacology and Therapeutics. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 1, 2018 Category: Cancer & Oncology Source Type: news

Simmons Cancer Center researchers part of historic CAR-T breakthrough
(UT Southwestern Medical Center) A historic study involving researchers from UT Southwestern's Harold C. Simmons Comprehensive Cancer Center demonstrates the effectiveness of CAR-T therapy, which uses genetically modified immune cells to treat acute lymphoblastic leukemia in children and young adults. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 1, 2018 Category: Cancer & Oncology Source Type: news

A bacterial duo linked to colon cancer
(American Association for the Advancement of Science) Scientists have identified a combination of bacteria that appears to increase the risk of colon cancer. Through a series of experiments in mice, they were able to pinpoint ways in which the two species of bacteria promote inflammation and break down the mucus layer of the colon. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 1, 2018 Category: Cancer & Oncology Source Type: news

Self-assembled 'hairy' nanoparticles could give a double punch to cancer
(Georgia Institute of Technology) 'Hairy' nanoparticles made with light-sensitive materials that assemble themselves could one day become 'nano-carriers' providing doctors a new way to simultaneously introduce both therapeutic drugs and cancer-fighting heat into tumors. That's one potential application for a new technology that combines water-repelling yet light-sensitive and water-absorbing materials into polymeric nano-reactors for creating photo-responsive gold nanoparticles. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 1, 2018 Category: Cancer & Oncology Source Type: news

Changes in genes involved in DNA repair and packaging linked to risk of multiple myeloma
(PLOS) Researchers have identified two gene regions that contribute to multiple myeloma, an inherited cancer that occurs in bone marrow, through a new method that makes use of human disease pedigrees. Nicola Camp and Rosalie Waller of the Huntsman Cancer Institute at the University of Utah, and colleagues, report their findings Feb. 1, 2018, in PLOS Genetics. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 1, 2018 Category: Cancer & Oncology Source Type: news

CNIO researchers discover a potential new therapeutic strategy for pancreatic cancer
(Centro Nacional de Investigaciones Oncol ó gicas (CNIO)) In most pancreatic cancer patients, the diagnosis is made when the disease is already advanced, and there is no effective treatment at present. There have been no significant advances to combat it in recent decades and unfortunately, its occurrence is on the increase. Now, a group of researchers from the Spanish National Cancer Research Centre (CNIO) may have found a new form of attack. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 1, 2018 Category: International Medicine & Public Health Source Type: news

Stand Up To Cancer awards 2018 Laura Ziskin Prize in Translational Research
(Entertainment Industry Foundation) SU2C awarded the $250,000 2018 Laura Ziskin Prize in Translational Research to Drs. Jos Jonkers of the Netherlands Cancer Institute and Helen Piwnica-Worms of the MD Anderson Cancer Center to examine the collection of neoantigens (or protein markers) present on patient-derived and laboratory models to more accurately replicate human tumors in laboratory models so new combinations of treatments can be more rapidly and accurately tested to speed more promising therapies to the clinic. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 1, 2018 Category: International Medicine & Public Health Source Type: news

Why basal cell tumors return when drug treatment stops
(Michigan Medicine - University of Michigan) A new study pinpoints a mechanism that controls how basal cell cancers respond to treatment and offers new ideas for controlling this disease when it gets tricky. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 1, 2018 Category: International Medicine & Public Health Source Type: news

Toy Foundation grants Nemours $825K to date for pediatric trauma-informed care
(Nemours) Children who face hospitalization for conditions such as cancer often experience traumatic stress related to their illness and treatment. The Toy Foundation is funding Nemours' research into the use of play as an intervention to lessen the traumatic nature of medical events or prevent traumatic stress in children. The idea is to emphasize physical and emotional safety through play to help patients and their families rebuild a sense of control and empowerment. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 1, 2018 Category: International Medicine & Public Health Source Type: news

PSMA PET/CT visualizes prostate cancer recurrence early, impacts radiation therapy
(Society of Nuclear Medicine and Molecular Imaging) A nuclear medicine scan may locate prostate cancer recurrence after radical prostatectomy early after disease recurrence and could help guide salvage radiotherapy, according to new research from the University of California Los Angeles (UCLA). The study, which utilizes PET/CT with gallium-68 prostate-specific membrane antigen (68Ga-PSMA-11), is documented in the featured article in the February issue of The Journal of Nuclear Medicine. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 1, 2018 Category: International Medicine & Public Health Source Type: news

New focus on where heart disease and breast cancer treatment meet
(MediaSource) The American Heart Association has released the first scientific statement about heart disease and breast cancer, calling for more research and collaboration between the fields of oncology and cardiology to treat and prevent both diseases. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 1, 2018 Category: Cancer & Oncology Source Type: news

Varian to Acquire Embattled Sirtex for $1.3B
Varian Medical Systems has revealed plans to acquire interventional oncology specialist Sirtex Medical for $1.3 billion. The proposed acquisition comes about a year after the New South Wales, Australia-based company fired CEO Gilman Wong, following an investigation into his share trading. In January 2017, the Sydney Morning Herald reported Wong was terminated after an investigation revealed he received $2.1 million from the sale of shares in Sirtex about one day after he told investors at the company’s annual general meeting that the company expected “double-digit” dose sales in 2017. Wong was replaced ...
Source: MDDI - February 1, 2018 Category: Medical Devices Authors: Omar Ford Tags: Medical Device Business Source Type: news

In Situ Vaccine Uses Immune Response to Treat Cancer
Antagonistic anti - OX40 antibody triggers T - cell immune response specific to tumor antigens (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - February 1, 2018 Category: Cancer & Oncology Tags: Oncology, Pathology, Pharmacy, Journal, Source Type: news

Heavy evening drinking now 6th biggest cause of disability
British people are living longer than before - but spending more of their retirement in poor health thanks to heart disease, liver disease, cancer and even alcohol-caused dementia. (Source: the Mail online | Health)
Source: the Mail online | Health - February 1, 2018 Category: Consumer Health News Source Type: news

Human trials to start for cancer vaccine
The team at Stanford University - which made a widely-used chemotherapy - claims just one injection into one tumor triggers a full-body response, attacking all other tumors that may have spread. (Source: the Mail online | Health)
Source: the Mail online | Health - February 1, 2018 Category: Consumer Health News Source Type: news

Breast cancer: 'Life-changing' drug given go-ahead for routine NHS use
A "LIFE-changing" drug for breast cancer patients has been given the final go-ahead for routine NHS use in England. The National Institute for Health and Care Excellence issued its final decision recommending Perjeta, also known as pertuzumab, for some women with breast cancer. (Source: Daily Express - Health)
Source: Daily Express - Health - February 1, 2018 Category: Consumer Health News Source Type: news

Changes to Cancer Drugs Fund increase NICE approvals
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - February 1, 2018 Category: Drugs & Pharmacology Source Type: news

Use of anti-cancer medicines & quot;cause for concern & quot; in Kosovo
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - February 1, 2018 Category: Drugs & Pharmacology Source Type: news

Enhancing responses to cancer immunotherapy
(Source: ScienceNOW)
Source: ScienceNOW - February 1, 2018 Category: Science Authors: Kvistborg, P., Yewdell, J. W. Tags: Immunology perspective Source Type: news

Different mutational rates and mechanisms in human cells at pregastrulation and neurogenesis
Somatic mosaicism in the human brain may alter function of individual neurons. We analyzed genomes of single cells from the forebrains of three human fetuses (15 to 21 weeks postconception) using clonal cell populations. We detected 200 to 400 single-nucleotide variations (SNVs) per cell. SNV patterns resembled those found in cancer cell genomes, indicating a role of background mutagenesis in cancer. SNVs with a frequency of>2% in brain were also present in the spleen, revealing a pregastrulation origin. We reconstructed cell lineages for the first five postzygotic cleavages and calculated a mutation rate of ~1.3 mutati...
Source: ScienceNOW - February 1, 2018 Category: Science Authors: Bae, T., Tomasini, L., Mariani, J., Zhou, B., Roychowdhury, T., Franjic, D., Pletikos, M., Pattni, R., Chen, B.-J., Venturini, E., Riley-Gillis, B., Sestan, N., Urban, A. E., Abyzov, A., Vaccarino, F. M. Tags: Genetics, Neuroscience r-articles Source Type: news

Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy
CD8+ T cell–dependent killing of cancer cells requires efficient presentation of tumor antigens by human leukocyte antigen class I (HLA-I) molecules. However, the extent to which patient-specific HLA-I genotype influences response to anti–programmed cell death protein 1 or anti–cytotoxic T lymphocyte–associated protein 4 is currently unknown. We determined the HLA-I genotype of 1535 advanced cancer patients treated with immune checkpoint blockade (ICB). Maximal heterozygosity at HLA-I loci ("A," "B," and "C") improved overall survival after ICB compared with patients wh...
Source: ScienceNOW - February 1, 2018 Category: Science Authors: Chowell, D., Morris, L. G. T., Grigg, C. M., Weber, J. K., Samstein, R. M., Makarov, V., Kuo, F., Kendall, S. M., Requena, D., Riaz, N., Greenbaum, B., Carroll, J., Garon, E., Hyman, D. M., Zehir, A., Solit, D., Berger, M., Zhou, R., Rizvi, N. A., Chan, T Tags: Genetics, Immunology, Medicine, Diseases reports Source Type: news

Patients with familial adenomatous polyposis harbor colonic biofilms containing tumorigenic bacteria
Individuals with sporadic colorectal cancer (CRC) frequently harbor abnormalities in the composition of the gut microbiome; however, the microbiota associated with precancerous lesions in hereditary CRC remains largely unknown. We studied colonic mucosa of patients with familial adenomatous polyposis (FAP), who develop benign precursor lesions (polyps) early in life. We identified patchy bacterial biofilms composed predominately of Escherichia coli and Bacteroides fragilis. Genes for colibactin (clbB) and Bacteroides fragilis toxin (bft), encoding secreted oncotoxins, were highly enriched in FAP patients’ colonic muc...
Source: ScienceNOW - February 1, 2018 Category: Science Authors: Dejea, C. M., Fathi, P., Craig, J. M., Boleij, A., Taddese, R., Geis, A. L., Wu, X., DeStefano Shields, C. E., Hechenbleikner, E. M., Huso, D. L., Anders, R. A., Giardiello, F. M., Wick, E. C., Wang, H., Wu, S., Pardoll, D. M., Housseau, F., Sears, C. L. Tags: Medicine, Diseases, Microbiology reports Source Type: news

Sponsored Collection | Precision medicine and cancer immunology in China
(Source: ScienceNOW)
Source: ScienceNOW - February 1, 2018 Category: Science Tags: Medicine, Diseases, Neuroscience opms-sups Source Type: news

Health Tip: Select the Right Cancer Team
(Source: Cancercompass News: Other Cancer)
Source: Cancercompass News: Other Cancer - February 1, 2018 Category: Cancer & Oncology Source Type: news

Cancer Survival Rates Vary Across the World
(Source: Cancercompass News: Breast Cancer)
Source: Cancercompass News: Breast Cancer - February 1, 2018 Category: Cancer & Oncology Source Type: news

Cancer 'Vaccine' Rids Body of Multiple Cancer Types -- in Mice
(Source: Cancercompass News: Breast Cancer)
Source: Cancercompass News: Breast Cancer - February 1, 2018 Category: Cancer & Oncology Source Type: news

Practice-Changing Regorafenib Data at 2018 GI Cancers Symposium Practice-Changing Regorafenib Data at 2018 GI Cancers Symposium
Dr John Marshall discusses new science in pancreatic and colorectal cancers, presented at the 2018 Gastrointestinal Cancers Symposium.Medscape Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 31, 2018 Category: Consumer Health News Tags: Hematology-Oncology Commentary Source Type: news

Elekta inks oncology co-selling deal with IBM Watson Health
Elekta (STO:EKTA B) said today it inked a collaborative sales deal with IBM‘s (NYSE:IBM) Watson Health through which Elekta will offer IBM’s Watson for Oncology with its cancer care solutions. With the deal, Elekta said it will begin offering the Watson for Oncology early this year as a clinical decision support solution paired with its digital cancer care solutions, including the Mosaiq oncology information systems. The combined offerings will be made available in markets including the US, Brazil, India, Australia and select European and Asian markets, Elekta said. “Joining forces with IBM Wats...
Source: Mass Device - January 31, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Oncology Elekta IBM Watson Health Source Type: news

Over $46 billion lost to premature cancer deaths in BRICS economies, UN research finds
Premature deaths as a result of cancer is costing major emerging economies tens of billions of dollars a year, a new United Nations health study has found, underlining the need for context-specific strategies for both prevention as well as treatment for those suffering from the disease. (Source: UN News Centre - Health, Poverty, Food Security)
Source: UN News Centre - Health, Poverty, Food Security - January 31, 2018 Category: International Medicine & Public Health Source Type: news

Bellicum's Cancer Drug Trials on Clinical Hold, Shares Tumble Bellicum's Cancer Drug Trials on Clinical Hold, Shares Tumble
Bellicum Pharmaceuticals Inc said the U.S. Food and Drug Administration had placed a clinical hold on U.S. trials of the company's experimental cancer drug after three cases of brain disease linked to head trauma.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 31, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Global Cancer Survival Rates Improve, but Wide Gaps Remain Global Cancer Survival Rates Improve, but Wide Gaps Remain
Cancer patients'survival prospects are improving, even for some of the deadliest types such as lung cancer, but there are huge disparities between countries, particularly for children, according to a study published on Wednesday.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 31, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Lower Risk of Some Cancers With Oral Contraceptives Applies Across Lifestyles Lower Risk of Some Cancers With Oral Contraceptives Applies Across Lifestyles
Women who use oral contraceptives for at least a decade may be less likely to develop ovarian or endometrial malignancies, and this benefit doesn ’ t seem to be diminished by other lifestyle risk factors, a U.S. study suggests.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 31, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Elekta teams up with IBM Watson Health
Radiation oncology vendor Elekta has formed a new partnership with IBM Watson...Read more on AuntMinnie.comRelated Reading: Elekta points to new MR/RT research Elekta partners with Alliance for Cancer Care IBM's Watson assigns patients to MRI contrast Strategic Radiology radiologists to work on Watson IBA, Elekta join forces on software development IBM Watson deal puts MedyMatch on the map (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 31, 2018 Category: Radiology Source Type: news

HPV May Lurk In Your Throat
URMC researchers found human papilloma virus (HPV), the culprit behind cervical and head and neck cancers, hiding in small pockets on the surface of tonsils. They believe HPV may evade the immune system in this hiding place, allowing the virus to lay in wait for an opportunity to reinstate an infection or invade the tonsil tissue to develop cancer. (Source: University of Rochester Medical Center Press Releases)
Source: University of Rochester Medical Center Press Releases - January 31, 2018 Category: Universities & Medical Training Authors: University of Rochester Medical Center Source Type: news

Research is Changing the Game for Melanoma Treatment
Wilmot Cancer Institute patients with advanced melanoma (stage III) now have more options for treatment, thanks to research co-authored by a University of Rochester Medical Center surgical oncologist and published in Lancet Oncology. (Source: University of Rochester Medical Center Press Releases)
Source: University of Rochester Medical Center Press Releases - January 31, 2018 Category: Universities & Medical Training Authors: University of Rochester Medical Center Source Type: news

Even obese breast cancer survivors may cut heart disease risk with exercise
(Reuters Health) - Exercise can help overweight and obese breast cancer survivors reverse what ’s known as metabolic syndrome - a cluster of conditions like high blood pressure and elevated blood sugar that raise risk for cardiovascular disease, stroke and diabetes - a new study suggests. (Source: Reuters: Health)
Source: Reuters: Health - January 31, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Internet-based program shows signs of improving cancer patients' lives
An eight-week online stress management program dramatically improved the quality of life of cancer patients, according to researchers at the University of Basel. (Source: Health News - UPI.com)
Source: Health News - UPI.com - January 31, 2018 Category: Consumer Health News Source Type: news

Biopsy rate is low after breast cancer
The rate of follow-up biopsies after breast cancer is relatively low -- a fact...Read more on AuntMinnie.comRelated Reading: 3D-printed breast biopsy device boosts accuracy Women overestimate breast cancer risk, prefer biopsy FDA clears GE MBI biopsy accessory AI could help reduce unnecessary breast biopsies FDA clears Hologic's Affirm prone biopsy system (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 31, 2018 Category: Radiology Source Type: news

Lancet: Cancer survival rates improve but vary widely
While cancer survival rates are generally increasing worldwide, there are still...Read more on AuntMinnie.comRelated Reading: Cancer deaths continue to fall, but CT lung screening lags Colorectal cancer mortality starts edging back up CDC: Cancer screening lags goals ACS: U.S. cancer death rates continue to fall JAMA: Cancer deaths fall 20% in U.S. since 1980 (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 31, 2018 Category: Radiology Source Type: news

Coffee in California May Soon Come with a Cancer Warning
Despite its long list of health benefits, coffee in California may soon come with a consumer warning about cancer. A lawsuit first filed by the Council for Education and Research on Toxics in 2010 seeks to require coffee sellers, including Starbucks, BP, Gloria Jean’s and 7-Eleven, to warn customers about the ingestion of acrylamide, a possibly cancer-causing chemical that’s produced when coffee beans are roasted. Under California’s Proposition 65, businesses are required to notify customers if their products contain any of 65 chemicals, including acrylamide, that are linked with cancer, birth defects or ...
Source: TIME: Health - January 31, 2018 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized Cancer Coffee Diet/Nutrition healthytime onetime toxins Source Type: news

Frequency of Breast Biopsies After Surgery? Finally, Answers Frequency of Breast Biopsies After Surgery? Finally, Answers
Remarkably, the medical literature has been unclear -- until now -- about how often patients treated for invasive breast cancer will need biopsies during follow-up.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 31, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news